ClinicalTrials.gov record NCT07844655

Wellness in PSP and CBD

Record copied from ClinicalTrials.gov: Oct 10, 2026AI summaries generated: Sep 28, 2026

Feasibility and Effectiveness of a Wellness Program in Individuals Living With Atypical Parkinsonism

StatusRecruitingThe study is currently enrolling participants. Only the study team can say whether a particular person can join.
Study typeInterventionalA study in which researchers assign participants to one or more interventions, such as a drug, procedure, device, behavioural programme or other approach, to measure their effects.
Age19 years old and older
SexAll
LocationCanada
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

This interventional study tests a virtual 8-week wellness program for people living with progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD). The program combines chair yoga, SongShine vocal strengthening, and peer support groups. Participants complete questionnaires before and after the program; care partners may complete a caregiver burden questionnaire when applicable.

What it is studying. The study evaluates whether the virtual multimodal lifestyle program is feasible (attendance and retention) and measures its effects on participants' emotional wellbeing and quality of life, and on caregiver burden.

What the researchers hope to learn. Assess feasibility (attendance and retention) of the program; measure effects on emotional wellbeing and quality of life; assess effects on caregiver burden.

What this study is about

The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.

The goal of this interventional study is to evaluate the feasiblity and effectiveness of a multimodal lifestyle program for individuals living with Progressive Supranuclear Palsy or Corticobasal Deneration. The main objectivess of the study are to:

  • Assess the feasibility of the program
  • Assess the effects of the program on emotional wellbeing and quality of life
  • Assess the effects of the program on caregiver burden

Participants will join an 8-week program combining chair yoga, vocal strengthening, and peer support groups, conducted virtually. Participants will complete pre- and post- intervention questionnaires related to emotional wellbeing and quality of life. When applicable, care partners will be asked to complete a caregiver burden questionnaire.

Interventions being studied

Being studied in this trial does not mean the treatment or procedure is approved or available for this condition.

Behavioral
  • Exercise and Peer Support

Eligibility

The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.

Inclusion criteria

  • Age over 18 years.
  • PSP or CBD diagnosis based on Movement Disorder Society criteria.

Exclusion criteria

  • Significant cognitive impairment.
  • Inability to fill in electronic questionnaires or understand study instructions.
  • Any contraindication for exercise based on the Physical Activity Readiness for Everyone Questionnaire (PAR-Q+).

Study description and what participation involves

The registry record has no detailed description beyond the summary above.

AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

Take part in an 8-week virtual wellness program combining chair yoga, SongShine vocal strengthening, and peer support group sessions. Complete questionnaires about emotional wellbeing and quality of life before and after the program; when applicable, care partners will be asked to complete a caregiver-burden questionnaire. Attendance and retention will be recorded. The registry requires screening for exercise safety using the PAR-Q+ questionnaire as an eligibility requirement; the record does not describe any other tests or in-person procedures performed during the study.

How the study is structured. All participants join the same 8-week virtual program (chair yoga, vocal strengthening, and peer support). The study is a single-group, non-masked interventional trial that records attendance/retention and uses pre‑ and post‑program questionnaires. There is no control or comparison group listed.

Questions you could ask

These questions are suggestions for a conversation with the study team or your own clinician, not advice.

  • The listed sites are in Canada. Is any of them reachable for me, and does the study help with travel?
  • Which of the eligibility criteria would need to be checked with tests before I could join?

More on progressive supranuclear palsy

Clinical trials45 trials listed for progressive supranuclear palsyEvery trial the registry lists for progressive supranuclear palsy, with recruitment status, phase and sites, updated from ClinicalTrials.gov.See all trials →Research updatesWhat changed in progressive supranuclear palsy researchLatest monthly update: September 2026. Includes: PSP vs Parkinsons. New research summarized each month in plain language, with links to every source paper.Read the latest update →

Important dates

Study start
Apr 10, 2026
Primary completion
Dec 31, 2027 (estimated)
Study completion
Dec 31, 2027 (estimated)
Target enrollment
30 participants (estimated)
Last updated on registry
Sep 28, 2026
Data verified
Oct 10, 2026

Sponsor and research team

The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.

Lead sponsor
Silke Cresswell
Collaborators
  • University of California, San Diego
  • CurePSP
  • Parkinson Canada
  • Pacific Parkinson's Research Centre

Central study contact

If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.

Participating sites (1)

Terms used on this page · explanations by MedicalUpdates.ai

contraindication
A reason a particular test or treatment should not be used for a person, for example a metal implant that rules out an MRI scan.
Inclusion Criteria
The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
Exclusion Criteria
The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.

The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.

← Back to clinical trials